Which biomarker is the earliest enzyme elevated in acute myocardial infarction?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

Which biomarker is the earliest enzyme elevated in acute myocardial infarction?

Explanation:
In acute myocardial infarction, heart cell injury releases substances into the blood in a characteristic sequence. Among enzymatic markers, CK-MB is the first to rise. CK-MB is an enzyme present mainly in cardiac muscle, so when cardiac cells are damaged it leaks into the bloodstream within about 3–6 hours, peaks around 24 hours, and returns to baseline in a couple of days. Troponin I, while highly specific for cardiac injury, is not an enzyme and tends to rise a bit later than CK-MB, staying elevated for a longer period. LDH is another enzyme that rises but later than CK-MB. Myoglobin appears even earlier than CK-MB, but it is not an enzyme, and its lack of specificity makes it less ideal as a sole cardiac marker. Thus, CK-MB is the earliest enzyme elevated in this setting.

In acute myocardial infarction, heart cell injury releases substances into the blood in a characteristic sequence. Among enzymatic markers, CK-MB is the first to rise. CK-MB is an enzyme present mainly in cardiac muscle, so when cardiac cells are damaged it leaks into the bloodstream within about 3–6 hours, peaks around 24 hours, and returns to baseline in a couple of days.

Troponin I, while highly specific for cardiac injury, is not an enzyme and tends to rise a bit later than CK-MB, staying elevated for a longer period. LDH is another enzyme that rises but later than CK-MB. Myoglobin appears even earlier than CK-MB, but it is not an enzyme, and its lack of specificity makes it less ideal as a sole cardiac marker.

Thus, CK-MB is the earliest enzyme elevated in this setting.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy